- Home
- CHMI vs TLSA Comparison
CHMI vs TLSA Comparison
Compare CHMI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMI
- TLSA
- Stock Information
- Founded
- CHMI 2012
- TLSA 2013
- Country
- CHMI United States
- TLSA United Kingdom
- Employees
- CHMI N/A
- TLSA N/A
- Industry
- CHMI Real Estate Investment Trusts
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- CHMI Real Estate
- TLSA Health Care
- Exchange
- CHMI Nasdaq
- TLSA Nasdaq
- Market Cap
- CHMI 89.2M
- TLSA 187.0M
- IPO Year
- CHMI 2013
- TLSA 2000
- Fundamental
- Price
- CHMI $2.79
- TLSA $1.45
- Analyst Decision
- CHMI Hold
- TLSA
- Analyst Count
- CHMI 2
- TLSA 0
- Target Price
- CHMI N/A
- TLSA N/A
- AVG Volume (30 Days)
- CHMI 343.4K
- TLSA 247.0K
- Earning Date
- CHMI 08-07-2025
- TLSA 07-22-2025
- Dividend Yield
- CHMI 21.43%
- TLSA N/A
- EPS Growth
- CHMI N/A
- TLSA N/A
- EPS
- CHMI N/A
- TLSA N/A
- Revenue
- CHMI $27,506,000.00
- TLSA N/A
- Revenue This Year
- CHMI N/A
- TLSA N/A
- Revenue Next Year
- CHMI $54.92
- TLSA N/A
- P/E Ratio
- CHMI N/A
- TLSA N/A
- Revenue Growth
- CHMI 19.59
- TLSA N/A
- 52 Week Low
- CHMI $2.34
- TLSA $0.63
- 52 Week High
- CHMI $3.95
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- CHMI 45.14
- TLSA 48.43
- Support Level
- CHMI $2.73
- TLSA $1.43
- Resistance Level
- CHMI $2.82
- TLSA $1.81
- Average True Range (ATR)
- CHMI 0.08
- TLSA 0.09
- MACD
- CHMI -0.01
- TLSA -0.02
- Stochastic Oscillator
- CHMI 40.00
- TLSA 18.53
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.